MRC1 and myeloid sarcoma: Recent studies that applied CyTOF technology for the analysis of peripheral blood mainly focusing on early MS, have shown phenotypic changes mainly in T cells, an increased abundance of T-bet-expressing B cells and a CD206+ classical monocyte subset, as well as a specific B cell subset only in the CSF of such patients (19, 20).